FITC Anti-Human CD34 Antibody [581] (AGEL1733)

FITC Anti-Human CD34 Antibody [581]

The Human CD34 Monoclonal Antibody FITC Conjugated (AGEL1733) is a specialized tool for research involving CD34, a transmembrane glycoprotein present on hematopoietic stem cells and endothelial cells. This unique antibody, conjugated with FITC for fluorescence detection, is specifically designed for flow cytometry applications in the analysis of CD34 expression in human samples.CD34 is a well-known marker for hematopoietic stem and progenitor cells, playing a crucial role in cell adhesion and signal transduction processes. The CD34 Monoclonal Antibody FITC Conjugated (AGEL1733) enables precise detection and quantification of CD34 expression, facilitating the identification and characterization of hematopoietic stem and progenitor cells in various research settings.

With its high specificity and sensitivity, this antibody is an essential tool for studies in stem cell biology, regenerative medicine, and hematopoiesis research. By targeting CD34-expressing cells, researchers can gain valuable insights into cell differentiation, proliferation, and mobilization processes, paving the way for advancements in therapeutic strategies for diseases such as leukemia, lymphoma, and other hematological disorders.Choose the Human CD34 Monoclonal Antibody FITC Conjugated (AGEL1733) for accurate and reliable flow cytometry analysis of CD34 expression, accelerating your research efforts in the field of hematopoietic stem cell biology and beyond.

Isotype:	Mouse IgG1, κ
Isotype Control:	FITC Mouse IgG1, κ Isotype Control[MOPC-21]
Form:	Liquid
Conjugation:	FITC
Recommended Use:	Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Spectrum: